Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 +0.86%78 Days Payable is 17.02 as of Dec. 2025, which is 4% below its 10-year median of 17.73. GuruFocus rates TSE:7782 with a GF Score™ of 78/100 and a GF Value™ of 円689.58 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 793 Medical Devices & Instruments companies, Sincere Co ranks worse than 95.33% on this metric.
Sincere Co's average Accounts Payable for the
three
months ended in Dec. 2025 was 円267 Mil. Sincere Co's Cost of Goods Sold for the
three
months ended in Dec. 2025 was 円1,430 Mil.
Hence, Sincere Co's Days Payable for the
three
months ended in Dec. 2025 was 17.02.
The historical rank and industry rank for Sincere Co's Days Payable or its related term are showing as below:
TSE:7782'
s Days Payable Range Over the Past 10 Years
Min: 9.46 Med: 17.73 Max: 26.36
Current: 16.65
During the past 12 years, Sincere Co's highest Days Payable was 26.36. The lowest was 9.46. And the median was 17.73.
TSE:7782's Days Payable is ranked worse than 95.33% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs TSE:7782: 16.65
Sincere Co's Days Payable
increased
from Dec. 2024 (0.00) to Dec. 2025 (17.02).
It may suggest that Sincere Codelayed paying its suppliers.
The historical data trend for Sincere Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7782 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sincere Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sincere Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sincere Co (TSE:7782) has a Days Payable of 17.02 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sincere Co and its competitors. This is near median its historical median of 17.73. Over the past decade, Sincere Co's Days Payable has ranged from 9.46 to 26.36. According to the industry distribution chart, Sincere Co ranks #756 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 95.3%.
Is Sincere Co's Days Payable too high?
Sincere Co's current Days Payable of 17.02 is near median its 10-year median of 17.73. Over the past 10 years, this metric has ranged from a low of 9.46 to a high of 26.36. The Medical Devices & Instruments industry median Days Payable is 68.47. Sincere Co's value of 17.02 is 75.1% below this industry median. Based on the distribution chart, Sincere Co ranks #756 out of 793 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sincere Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #756 out of 793 companies for Days Payable. This places Sincere Co in the lower half of its industry. The industry median Days Payable is 68.47. Sincere Co's value of 17.02 is 75.1% below this benchmark. Historically, Sincere Co's own Days Payable has ranged from 9.46 to 26.36 over the past decade. While the company's 10-year median is 17.73 vs. the industry median of 68.47, Sincere Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current Days Payable of 17.02 is 75.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current Days Payable is 17.02, which is near median its own 10-year median of 17.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円689.58, compared to a current price of 円467.00 — trading 32.3% below its estimated fair value. The current Days Payable is 17.02, which is near median its 10-year median of 17.73 and 75.1% below the Medical Devices & Instruments industry median of 68.47. Sincere Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current Days Payable is 17.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円467.00 is trading 32.3% below its estimated GF Value™ of 円689.58.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
Days Payable: 17.02 (near median its 10-year median of 17.73)
GF Value™: 円689.58 vs. price of 円467.00 (32.3% below fair value)
Industry Position: 75.1% below the Medical Devices & Instruments median (#756 of 793)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
78GF Score
Get the complete analysis for TSE:7782
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
